Cannabis Law Report

MARCH 18, 2022

A new ASTM International standard seeks to create an internationally recognized symbol that indicates a product contains intoxicating cannabinoids. The cannabis technical committee at ASTM, D37, developed the standard for the International Intoxicating Cannabinoid Product Symbol (IICPS). ASTM International members David L.

Cannabinoids 52

Cannabinoids Research and Development Topical THC 52

Kind Meds (Cannabis Education Blog)

AUGUST 15, 2022

However, with the ongoing debate about the benefits and drawbacks of cannabinoids and other cannabis compounds , it can seem as if cannabis is an emerging trend. Cannabinoid Recognition. The medical field first began recognizing the benefits of the cannabinoid compounds within cannabis in 1850. What Are Cannabinoids?

Cannabinoids 52

Cannabinoids Research and Development Strains Sleep 52

Healer

JUNE 8, 2023

With cannabis and phytocannabinoids like THC, CBD and CBG rapidly becoming highly prized therapeutic agents, many people are turning to cannabinoids for life improvement. Unfortunately, there is a lot of misinformation that can be a stumbling block to those who could truly benefit from cannabinoids like CBD and THC.

Education 40

Education Cannabinoids Programs Research and Development 40

MMJ Recs

MAY 25, 2024

Medical marijuana has been a hot topic over the years – from the stigma it surrounds the cannabis industry to its legalization in US states and its research and use for treating various ailments. Let’s go over the three main components of ECS to better understand, they are: endocannabinoids, cannabinoid receptors, and enzymes.

Patients 105

Patients Marijuana Cannabinoids Chronic Pain 105

Kind Meds (Cannabis Education Blog)

JANUARY 27, 2022

Lately, the cannabinoid CBN (or cannabinol) has been rising in popularity. CBN is a cannabinoid that can be synthesized out of THC. Cannabinol – more commonly known as CBN – is one of over one hundred cannabinoids found in the cannabis plant. The CBN cannabinoid begins to form when THC is oxidized. What Is CBN?

Cannabinoids 52

Cannabinoids Treatment Extraction THC 52

Cannabis Law Report

MAY 29, 2022

Earlier this month, Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) urging both agencies to advance research on the therapeutic effects of psychedelic drugs. [1] Recent Regulatory Developments. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Veriheal

MARCH 22, 2023

Consuming alcohol heavily in young adulthood is associated with an increased likelihood of developing alcohol use disorder (AUD) , the most widespread substance-related disorder worldwide. Notably, endocannabinoids are not the same as cannabinoids as the body creates them naturally, whereas cannabinoids are found in the cannabis plant.

Research and Development 98

Research and Development Cannabinoids Treatment Sleep 98

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. None of the participants had been using any cannabinoid-based products prior to this study.

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

The Cannigma

DECEMBER 20, 2021

Recent scientific studies suggest that different cannabinoids and other cannabis-derived molecules (e.g Researchers are still in the early stages of learning how exactly cannabinoids affect skin health, but some of the results are compelling. But how does cannabis actually affect the skin?

Terpenes 133

Terpenes Cannabinoids Topical Research and Development 133

MMJ Recs

DECEMBER 30, 2023

Cannabinoids, such as THC and CBD, interact with the endocannabinoid system in the brain, influencing mood, stress response, and emotional regulation. Research suggests that the modulation of the endocannabinoid system may have therapeutic implications for mental health disorders and in simple areas such as using cannabis for stress relief.

Conditions 98

Conditions Marijuana Research and Development Treatment 98

PrestoDoctor

JULY 12, 2023

In this post, we will look at how cannabis can protect the brain and talk about recent research. Early studies indicate that cannabinoids like THC and CBD may have neuroprotective properties and could potentially help with Alzheimer’s disease. Currently, scientists are looking into using cannabis for Alzheimer’s disease.

Research and Development 98

Research and Development Cannabinoids Treatment Cannabis 98

Cannabis Law Report

JANUARY 10, 2022

Minor Cannabinoids Market Size, Share & Trends Analysis Report by Product (CBG, CBC, CBN, THCV, CBGA), by Application (Pain Management, Neurological Disorders), and Segment Forecasts, 2021-2028” report has been added to ResearchAndMarkets.com’s offering. minor cannabinoids market size is expected to reach USD 26.2

Cannabinoids 52

Cannabinoids Clinical Trials Research and Development Supply Chain 52

Cannabis Law Report

NOVEMBER 17, 2021

Launch of Zylem ™ 20:1 further expands ZYUS product offerings with new cannabinoid formulation. The launch of this formulation marks an important milestone in ZYUS’ mission to elevate cannabinoids as a standard of care and leverage their transformational potential.

Cannabinoids 52

Cannabinoids Patients Research and Development Extraction 52

Greencamp

AUGUST 25, 2018

I wanted to see just how good cannabis might be for this condition, and so I decided to go over the available research. Both genetic and environmental factors play a role in developing this disease. Lupus usually starts to develop between the ages of 14 and 45, but it can happen anytime. Here’s what I found. What is lupus?

Cannabinoids 92

Cannabinoids Strains Research and Development Sativa 92

SpeedWeed

APRIL 30, 2021

The German government is now funding cannabis research on cannabinoid extractions and additives to food. It is easy to categorize this development in the big bucket of the times they are a’changing—and at a rather rapid pace. That is a big story. . However, here is the strange dichotomy at play within the German government.

Extraction 52

Extraction CBD Research and Development Food 52

PrestoDoctor

SEPTEMBER 26, 2023

Cannabis and Mental Health Issues The association between cannabis use and mental health has long been a topic of interest. Research suggests that cannabis can affect various aspects of mental health , including mood, cognition, and behavior. Research suggests that there is indeed a link between cannabis use and mental health issues.

Research and Development 105

Research and Development Chronic Pain Sleep Conditions 105

Cannabis Law Report

JULY 28, 2021

To date, the clinic network has seen over 75,000 unique patients and has conducted extensive research in cannabinoid therapy as it relates to sleeping disorders, opioid reduction and other topics. General Research: The Company has engaged General Research GmbH (“GR”) to increase its exposure to investors in Europe.

Clinical Trials 81

Clinical Trials Research and Development Treatment Therapy 81

Cannabis Law Report

FEBRUARY 1, 2022

New softgel capsule products further expand ZYUS’ medical cannabinoid offerings and provide patients a precise method for dosing. The launch of these two new softgel products marks another important milestone in ZYUS’ mission to elevate cannabinoids as a standard of care and leverage their transformational potential.

Cannabinoids 52

Cannabinoids Patients Research and Development Media 52

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. None of the participants had been using any cannabinoid-based products prior to this study.

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

Cannabis Law Report

JULY 13, 2021

LEP is a biotechnology company focused on the research, development, and commercialization of novel cannabinoid therapies and innovative drug delivery systems that provide safe and effective topical solutions for pain management. from 2021 to 2028. About Leading Edge Pharms, Inc. Leading Edge Pharms, Inc.

Research and Development 105

Research and Development Topical Cannabinoids Therapy 105

Otherside Farms

JULY 4, 2022

The study of cannabinoids is fascinating because it sheds light on the body’s endocannabinoid system (ECS). What exactly are cannabinoids? CBC Wholesale and other cannabinoids also affect the ECS. A state of equilibrium gets maintained in your body through the activity of cannabinoids and their receptors.

Research and Development 96

Research and Development Cannabinoids THC Concentrates 96

MMJ Recs

DECEMBER 28, 2023

In this article, we’ll talk about a few of the most common conditions for which medical marijuana is prescribed, exploring the growing body of research and real-world experiences that contribute to its acceptance as a viable therapeutic option. CBD, a non-psychoactive cannabinoid, has gained attention for its anti-anxiety effects.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

PrestoDoctor

JULY 10, 2023

Marijuana has become a hot topic recently, with many states legalizing the drug for both medical and recreational use. This can lead to a condition known as gynecomastia, or the development of breast tissue in men. This can lead to a condition known as gynecomastia, or the development of breast tissue in men.

Research and Development 75

Research and Development Cannabis Conditions THC 75

United Patients Group

OCTOBER 25, 2023

Medical marijuana’s therapeutic effects are primarily due to its active compounds, known as cannabinoids. The two primary cannabinoids are delta-9-tetrahydrocannabinol ( THC ) and cannabidiol ( CBD ). – Topical (Lotions, Balms, or Patches): Ideal for localized pain relief without systemic effects.

Marijuana 92

Marijuana Patients Research and Development Edibles 92

Healer

JUNE 20, 2023

  The Healer Cannabis and Dementia webinar includes the latest research and case studies of patients successfully using cannabis and hemp to help with dementia challenges such as agitation, wandering, aggressive behaviors, poor nutrition, pain, sleep and even cognitive abilities.

Research and Development 98

Research and Development Sleep Topical Hemp 98

Medicinal Genomics

JULY 13, 2023

So here are just a dozen new developments, breakthroughs, and aha moments from this year’s summit that might just convince you to circle CannMed 24 on your calendar right now. the VP of Research & Development at Biopharmaceutical Research Company, Inc., But if you weren’t able to be there, you wouldn’t know that.

Research and Development 52

Research and Development Cannabinoids Medicine DEA 52

Medicinal Marijuana Association

FEBRUARY 11, 2024

Endocannabinoid System Overview Understanding the endocannabinoid system is crucial for grasping how cannabinoids interact with your body to regulate various physiological functions and maintain balance. Cannabinoids such as CBD work by binding to specific receptors and influencing various physiological processes.

CBD 52

CBD Research and Development Topical Cannabinoids 52

Greencamp

AUGUST 16, 2018

In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Exploring the available research on ALS and cannabinoids. As few as 10% of ALS patients live longer than 10 years after being diagnosed.

Strains 94

Strains Cannabinoids Research and Development Indica 94

Cannabis Law Report

MAY 28, 2021

But there is a factor that could serve to speed up the process – scientific research. The company has taken its deep pharmaceutical background and focused on developing an advanced, patented, effective, and safe cannabinoid delivery technology called Invisicare®. CBD-infused topicals are expected to reach $4.5

Medicine 64

Medicine Wellness and Beauty Research and Development Topical 64

The Cannigma

JUNE 14, 2021

For more than 50 years, if you wanted to do cannabis research in the United States, federal law said you had to get the cannabis from the University of Mississippi. We are absolutely ecstatic,” George Hodgin, the CEO of the Castroville, California based Biopharmaceutical Research Co. BRC) told The Cannigma this week.

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

United Patients Group

DECEMBER 5, 2023

It’s a topic of serious conversation, vibrant debate, and ongoing research. Despite the controversy surrounding its legalization and use, there’s no denying the increasing amount of research supporting its therapeutic potential. In this day and age, the use of medical cannabis is no longer a fringe idea.

Research and Development 97

Research and Development Treatment Patients Conditions 97

MMJ Recs

MARCH 16, 2024

Economic Growth and Job Creation of the medical marijuana industry The medical cannabis sector serves as a catalyst for economic expansion and workforce development in regions where it’s legalized. Market research helps identify trends and shifts in consumer preferences, allowing businesses to tailor their offerings accordingly.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

MMJ Recs

MAY 15, 2024

For those who suffer from post-traumatic stress disorder (PTSD), they develop a response to traumatic events or experiences, such as accidents, natural disasters, or acts of violence. Cannabidiol (CBD) and tetrahydrocannabinol (THC), two prominent cannabinoids found in cannabis, exhibit properties that may offer relief from anxiety.

Marijuana 105

Marijuana Therapy Treatment Sleep 105

Cannabis Law Report

JANUARY 21, 2022

DUBLIN–(BUSINESS WIRE)–The “CBD Consumer Health Market Research Report by Product, by Distribution Channel, by Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. Growing adoption of CBD topicals across the world.

Research and Development 52

Research and Development CBD Pharmaceutical Business 52

Illinois News Joint

NOVEMBER 3, 2023

Cannabis remediation is a topic of hot debate among the industry that will only build as consumers become more educated. This batch of flower tested at 0.67% THC, 25.23% THCa, and 26.27% total cannabinoids. The efficacy of these products has not been confirmed by FDA-approved research.

Indica 84

Indica Hybrid Trichome Research and Development 84

TheAnswerPage

JULY 20, 2021

Are cannabinoids lipophilic or hydrophylic? Cannabinoids are actually highly lipophilic. In fact, oral and topical cannabinoid products are often administered with a carrier to facilitate their absorption. Research, Society and Development, [S. de; SILVA , A. de; SILVA , A. ABREU , L. GONZAGA, R.

Research and Development 59

Research and Development Cannabinoids Topical Medicine 59

PrestoDoctor

JANUARY 30, 2024

Connection between cannabis use and psychosis The connection between cannabis use and psychosis has been a topic of much research and debate. Studies have shown that individuals who use cannabis are at an increased risk of developing psychotic symptoms. This is especially true if they have a predisposition to psychosis.

Research and Development 52

Research and Development Treatment Conditions Education 52